Control Menstrual Cramp Relief

Product NDC
58133-010
Requested package NDC
58133-010-03
11-digit product format
581330010
Labeler code
58133
Product ID
58133-010_c9f0a39a-fedb-200f-e053-2995a90aa888
Type
HUMAN OTC DRUG
Nonproprietary name
Menthol
Dosage form
CREAM
Route
TOPICAL
Labeler
Cosmetic Specialty Labs, Inc.
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2021-03-04
Marketing end
0000-00-00
Substance
MENTHOL
Active strength
3 g/100mL
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage58133-01058133-010-03DDiscontinued by firm2026-10-05
excluded packagepackage58133-01058133-010-03IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 27 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31IInactivated by FDA302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14IInactivated by FDA834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08IInactivated by FDA1332a3947898…d4bfe170f9cd…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
58133-010-012024-07-30C16284748780-11e7a6dab-1d27-a2ce-e063-dadaa90aadf7KRT packet
58133-010-032024-01-30C16284748780-11030e365-14de-111a-e063-dadaa90a10e2c9f0a39a-feda-200f-e053-2995a90aa888

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58133-010-01Control Menstrual Cramp Relief7.5 mL in 1 PACKETCREAM7.51
58133-010-03Control Menstrual Cramp Relief89 mL in 1 TUBECREAM891

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
58133-010-03ML - Milliliter58133-0109da76123-c615-425e-adac-c084d8b112e112022-04-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58133-010CONTROL MENSTRUAL CRAMP RELIEF (MENTHOL) CREAM [COSMETIC SPECIALTY LABS, INC.]1Legacy NDC, 1 package rows20210821_c9f0a39a-feda-200f-e053-2995a90aa888.zip
58133-010CONTROL MENSTRUAL CRAMP RELIEF (MENTHOL) CREAM [COSMETIC SPECIALTY LABS, INC.]1Legacy NDC, 1 package rows20230525_fc73dde9-9df4-beca-e053-6394a90aaf0d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1442261menthol 3 % Topical CreamPSNc9f0a39a-feda-200f-e053-2995a90aa8881
1442261menthol 3 % Topical CreamPSNfc73dde9-9df4-beca-e053-6394a90aaf0d1
1442261menthol 30 MG/ML Topical CreamSCDc9f0a39a-feda-200f-e053-2995a90aa8881
1442261menthol 30 MG/ML Topical CreamSCDfc73dde9-9df4-beca-e053-6394a90aaf0d1
1442261menthol 3 % Topical CreamSYc9f0a39a-feda-200f-e053-2995a90aa8881
1442261menthol 3 % Topical CreamSYfc73dde9-9df4-beca-e053-6394a90aaf0d1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58133-010-035813300100389 mL in 1 TUBE (58133-010-03) 89 ml2021-03-040000-00-00NoNoCurrent